BB
MYOK

BB Biotech’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

BB Biotech’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$65.8M Buy
1,264,913
+387,647
+44% +$17.9M 1.65% 21
2018
Q4 		$42.9M Buy
877,266
+367,266
+72% +$20.2M 1.37% 22
2018
Q3 		$33.3M Buy
510,000
+30,000
+6% +$1.76M 0.88% 27
2018
Q2 		$23.8M Buy
+480,000
New +$23.2M 0.69% 26

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BB Biotech's MYOK Position: Q1 2019 in Review

BB Biotech increased its MyoKardia, Inc. Common Stock (MYOK) stake by 44% in Q1 2019, buying an estimated $17.9M and bringing the position to 1,264,913 shares worth $65.8M. The position accounts for 1.65% of the portfolio, ranked #21.

BB Biotech first reported a position in MYOK in Q2 2018 and has held it in 4 quarters since. 168 funds tracked by Wall St. Rank hold MYOK as of Q1 2019.

  • BB Biotech held 1,264,913 shares of MyoKardia, Inc. Common Stock worth $65.8M as of Q1 2019.
  • BB Biotech bought 387,647 MyoKardia, Inc. Common Stock shares in Q1 2019, an estimated $17.9M.
  • MyoKardia, Inc. Common Stock made up 1.65% of BB Biotech's portfolio in Q1 2019, its #21 holding.
  • BB Biotech first reported a position in MyoKardia, Inc. Common Stock in Q2 2018 and has held it in 4 quarters since.
  • 168 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2019.

Based on BB Biotech's 13F filing for Q1 2019, filed 13 May 2019.